Alerts will be sent to your verified email
Verify EmailFABINO
Fabino Enterprises
|
Zyden Gentec
|
Kobo Biotech
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
0.76 % | -24.76 % | -1.77 % |
5yr average Equity Multiplier
|
2.01 | 2.0 | 4.06 |
5yr Average Asset Turnover Ratio
|
0.98 | 0.21 | 0.54 |
5yr Avg Net Profit Margin
|
0.54 % | -137.59 % | -3.79 % |
Price to Book
|
0.0 | n/a | 0.0 |
P/E
|
87.72 | n/a | 0.0 |
5yr Avg Cash Conversion Cycle
|
59.85 Days | 785.76 Days | 0.0 |
Inventory Days
|
81.8 Days | 134.34 Days | 89.28 Days |
Days Receivable
|
131.05 Days | 803.05 Days | 0.0 |
Days Payable
|
60.4 Days | 421.99 Days | 147.48 Days |
5yr Average Interest Coverage Ratio
|
5.69 | -2.08 | 0.99 |
5yr Avg ROCE
|
1.29 % | -6.92 % | 11.79 % |
5yr Avg Operating Profit Margin
|
1.24 % | -95.87 % | 8.83 % |
5 yr average Debt to Equity
|
0.14 | 0.68 | 1.62 |
5yr CAGR Net Profit
|
-4.36 % | -1.66 % | n/a |
5yr Average Return on Assets
|
0.49 % | -15.88 % | -0.89 % |
Shareholdings
|
|||
Promoter Holding
|
56.82 % | 0.0 | 44.95 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -17.28 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Fabino Enterprises
|
Zyden Gentec
|
Kobo Biotech
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|